These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 20923243
1. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. Borghi C, Cicero AF. Clin Drug Investig; 2010; 30(12):843-54. PubMed ID: 20923243 [Abstract] [Full Text] [Related]
2. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension. Rump LC. Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943 [Abstract] [Full Text] [Related]
3. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril. Chatzikyrkou C, Haller H, Menne J. Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194 [Abstract] [Full Text] [Related]
4. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Antza C, Stabouli S, Kotsis V. Vasc Health Risk Manag; 2016 Aug; 12():443-451. PubMed ID: 27895487 [Abstract] [Full Text] [Related]
5. Role of the fixed-dose combination lercanidipine-enalapril in renal protection. Egan CG, Pontremoli R. J Nephrol; 2011 Aug; 24(4):428-37. PubMed ID: 21279953 [Abstract] [Full Text] [Related]
6. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. Agrawal R, Marx A, Haller H. J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117 [Abstract] [Full Text] [Related]
7. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril. Barrios V, Escobar C, Echarri R. Vasc Health Risk Manag; 2008 Jan; 4(4):847-53. PubMed ID: 19066001 [Abstract] [Full Text] [Related]
8. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine. Tocci G, Palano F, Pagannone E, Chin D, Ferrucci A, Volpe M. Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207 [Abstract] [Full Text] [Related]
9. Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study. Sierra A, Roca-Cusachs A, Redón J, Marín R, Luque M, Figuera M, Garcia-Garcia M, Falkon L. Clin Drug Investig; 2009 Feb; 29(7):459-469. PubMed ID: 19499963 [Abstract] [Full Text] [Related]
10. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Rosei CA, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Rosei EA. J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999 [Abstract] [Full Text] [Related]
11. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial. Mancia G, Coca A, Chazova I, Girerd X, Haller H, Pauletto P, Pupek-Musialik D, Svyshchenko Y, FELT investigators. J Hypertens; 2014 Aug; 32(8):1700-7; discussion 1707. PubMed ID: 24906174 [Abstract] [Full Text] [Related]
12. [Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension]. Gosteva EV, Vasil'eva LV. Kardiologiia; 2015 Aug; 55(2):32-6. PubMed ID: 26164986 [Abstract] [Full Text] [Related]
13. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome. Ghiadoni L, Bruno RM, Cartoni G, Stea F, Magagna A, Virdis A, Grassi D, Ferri C, Taddei S. Vascul Pharmacol; 2017 May; 92():16-21. PubMed ID: 26070528 [Abstract] [Full Text] [Related]
14. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice. Cicero AF, Gerocarni B, Rosticci M, Borghi C. Clin Exp Hypertens; 2012 May; 34(2):113-7. PubMed ID: 21967031 [Abstract] [Full Text] [Related]
15. [Treatment of arteril hypertension in patients with chronic kidney disease: a fixed combination of lercanidipine and enalapril]. Minushkina LO. Kardiologiia; 2013 May; 53(12):64-9. PubMed ID: 24800484 [Abstract] [Full Text] [Related]
16. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies. Cleophas TJ, van Ouwerkerk BM, van der Meulen J, Zwinderman AH. Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986 [Abstract] [Full Text] [Related]
17. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients. Derosa G, Bonaventura A, Romano D, Bianchi L, Fogari E, D'Angelo A, Maffioli P. J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387 [Abstract] [Full Text] [Related]
18. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? Burnier M, Pruijm M, Wuerzner G. Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074 [Abstract] [Full Text] [Related]
19. Fixed-dose combination lercanidipine/enalapril. Hair PI, Scott LJ, Perry CM. Drugs; 2007 Aug; 67(1):95-106; discussion 107-8. PubMed ID: 17209666 [Abstract] [Full Text] [Related]